NA
Navellier & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,427
| Closed | -$4.6M | – | 376 |
|
|
2024
Q4 | $4.6M | Buy |
11,427
+395
| +4% | +$159K | 0.55% | 44 |
|
|
2024
Q3 | $5.13M | Sell |
11,032
-669
| -6% | -$311K | 0.7% | 33 |
|
|
2024
Q2 | $5.48M | Sell |
11,701
-160
| -1% | -$75K | 0.64% | 33 |
|
|
2024
Q1 | $4.96M | Sell |
11,861
-537
| -4% | -$224K | 0.61% | 41 |
|
|
2023
Q4 | $5.04M | Buy |
12,398
+568
| +5% | +$231K | 0.76% | 34 |
|
|
2023
Q3 | $4.11M | Buy |
+11,830
| New | +$4.11M | 0.7% | 37 |
|